NAS:BRKR (USA) Also trade in: Germany

Bruker Corp

$ 48.8 -0.81 (-1.63%)
Volume: 597,574 Avg Vol (1m): 798,547
Market Cap $: 7.66 Bil Enterprise Value $: 7.70 Bil
P/E (TTM): 41.39 P/B: 8.46
Earnings Power Value 13.26
Net Current Asset Value 0.09
Tangible Book 2.28
Projected FCF 14.06
Median P/S Value 23.61
Graham Number 7.77
Peter Lynch Value 19.42
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 7.2/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.89
Cash-To-Debt range over the past 10 years
Min: 0.13, Med: 1.28, Max: 9.3
Current: 0.89
0.13
9.3
Equity-to-Asset 0.41
Equity-to-Asset range over the past 10 years
Min: 0.14, Med: 0.42, Max: 0.69
Current: 0.41
0.14
0.69
Debt-to-Equity 0.37
Debt-to-Equity range over the past 10 years
Min: 0.07, Med: 0.37, Max: 1.72
Current: 0.37
0.07
1.72
Debt-to-EBITDA 1.02
Debt-to-EBITDA range over the past 10 years
Min: 0.83, Med: 1.53, Max: 2.04
Current: 1.02
0.83
2.04
Interest Coverage 22.20
Interest Coverage range over the past 10 years
Min: 9.84, Med: 14.93, Max: 28.84
Current: 22.2
9.84
28.84
Piotroski F-Score 6
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.12
DISTRESS
GREY
SAFE
Beneish M-Score -2.16
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 24.51%
WACC 10.47%

Profitability & Growth : 7/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 14.18
Operating Margin range over the past 10 years
Min: 7.24, Med: 11.13, Max: 14.18
Current: 14.18
7.24
14.18
Net Margin % 9.53
Net Margin range over the past 10 years
Min: 3.13, Med: 5.93, Max: 9.53
Current: 9.53
3.13
9.53
ROE % 21.92
ROE range over the past 10 years
Min: 7.03, Med: 14.87, Max: 22.27
Current: 21.92
7.03
22.27
ROA % 9.27
ROA range over the past 10 years
Min: 2.94, Med: 5.66, Max: 9.27
Current: 9.27
2.94
9.27
ROC (Joel Greenblatt) % 38.09
ROC (Joel Greenblatt) range over the past 10 years
Min: 19.4, Med: 33.65, Max: 40.15
Current: 38.09
19.4
40.15
3-Year Total Revenue Growth Rate 5.30
3-Year Revenue Growth Rate range over the past 10 years
Min: 0, Med: 9.7, Max: 43.4
Current: 7.9
0
43.4
3-Year Total EBITDA Growth Rate 18.40
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 8.2, Max: 310.4
Current: 21.3
0
310.4
3-Year EPS w/o NRI Growth Rate 23.90
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: -1.6, Max: 59.4
Current: 23.9
0
59.4

» BRKR's 30-Y Financials

Financials (Next Earnings Date: 2019-08-02)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:BRKR

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Diagnostics & Research » Medical Diagnostics & Research    NAICS : 334516    SIC : 3826
Compare XPAR:ERF NAS:GH NAS:ICLR NYSE:CRL NAS:PRAH NYSE:QGEN NYSE:BIO.B MIL:DIA XPAR:BIM NAS:SYNH NYSE:PKI SHSE:603658 SZSE:300676 NAS:NEOG NAS:QDEL NAS:MEDP BSP:DASA3 SHSE:603882 XTER:SRT NYSE:NVTA
Traded in other countries BKD.Germany
Address 40 Manning Road, Billerica, MA, USA, 01821
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. The vast majority of revenue comes from the scientific instruments segment, which develops tools based on magnetic resonance, mass spectrometry, and X-ray technologies. The remainder of the firm's business comes from the energy and superconductor technology segment, which manufactures superconducting materials primarily used in magnetic resonance imaging, nuclear magnetic resonance, and fusion energy research. The largest proportion of Bruker's revenue comes from Europe, though the firm also has a significant presence in the United States and Asia.

Ratios

Current vs industry vs history
PE Ratio (TTM) 41.39
PE Ratio range over the past 10 years
Min: 7.21, Med: 32.94, Max: 73.45
Current: 41.39
7.21
73.45
Forward PE Ratio 30.67
N/A
PE Ratio without NRI 41.39
PE without NRI range over the past 10 years
Min: 7.21, Med: 32.94, Max: 73.45
Current: 41.39
7.21
73.45
Price-to-Owner-Earnings 55.37
Price-to-Owner-Earnings range over the past 10 years
Min: 10.85, Med: 40.63, Max: 6933.33
Current: 55.37
10.85
6933.33
PB Ratio 8.46
PB Ratio range over the past 10 years
Min: 1.93, Med: 4.76, Max: 8.92
Current: 8.46
1.93
8.92
PS Ratio 3.99
PS Ratio range over the past 10 years
Min: 0.5, Med: 1.93, Max: 4.17
Current: 3.99
0.5
4.17
Price-to-Free-Cash-Flow 48.34
Price-to-Free-Cash-Flow range over the past 10 years
Min: 10.25, Med: 30.89, Max: 147.38
Current: 48.34
10.25
147.38
Price-to-Operating-Cash-Flow 36.55
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 5.71, Med: 22.11, Max: 50.96
Current: 36.55
5.71
50.96
EV-to-EBIT 29.67
EV-to-EBIT range over the past 10 years
Min: 4.7, Med: 21.3, Max: 33.6
Current: 29.67
4.7
33.6
EV-to-EBITDA 23.50
EV-to-EBITDA range over the past 10 years
Min: 4.3, Med: 16.2, Max: 24.7
Current: 23.5
4.3
24.7
EV-to-Revenue 4.00
EV-to-Revenue range over the past 10 years
Min: 0.6, Med: 1.9, Max: 4.2
Current: 4
0.6
4.2
PEG Ratio 2.96
PEG Ratio range over the past 10 years
Min: 0.09, Med: 2.64, Max: 270.82
Current: 2.96
0.09
270.82
Shiller PE Ratio 72.57
Shiller PE Ratio range over the past 10 years
Min: 35.08, Med: 50, Max: 109.21
Current: 72.57
35.08
109.21
Current Ratio 2.12
Current Ratio range over the past 10 years
Min: 1.26, Med: 2.22, Max: 4.99
Current: 2.12
1.26
4.99
Quick Ratio 1.27
Quick Ratio range over the past 10 years
Min: 0.43, Med: 1.3, Max: 3.95
Current: 1.27
0.43
3.95
Days Inventory 187.73
Days Inventory range over the past 10 years
Min: 178.02, Med: 199.13, Max: 259.2
Current: 187.73
178.02
259.2
Days Sales Outstanding 68.32
Days Sales Outstanding range over the past 10 years
Min: 52.76, Med: 60.67, Max: 68.78
Current: 68.32
52.76
68.78
Days Payable 45.72
Days Payable range over the past 10 years
Min: 26.4, Med: 29.9, Max: 45.72
Current: 45.72
26.4
45.72

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 0.33
Trailing Dividend Yield range over the past 10 years
Min: 0.14, Med: 0.52, Max: 0.76
Current: 0.33
0.14
0.76
Dividend Payout Ratio 0.14
Dividend Payout Ratio range over the past 10 years
Min: 0.14, Med: 0.17, Max: 0.33
Current: 0.14
0.14
0.33
Forward Dividend Yield % 0.32
N/A
Yield-on-Cost (5-Year) % 0.32
Yield-on-Cost (5y) range over the past 10 years
Min: 0.14, Med: 0.52, Max: 0.76
Current: 0.32
0.14
0.76
3-Year Share Buyback Rate 1.80
3-Year Share Buyback Rate range over the past 10 years
Min: -22.1, Med: -3.1, Max: 0
Current: 1.8
-22.1
0

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 21.42
Price-to-Tangible-Book range over the past 10 years
Min: 1.34, Med: 5.52, Max: 21.88
Current: 21.42
1.34
21.88
Price-to-Projected-FCF 3.48
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.91, Med: 2.3, Max: 10.62
Current: 3.48
0.91
10.62
Price-to-Median-PS-Value 2.07
Price-to-Median-PS-Value range over the past 10 years
Min: 0.31, Med: 0.94, Max: 21.65
Current: 2.07
0.31
21.65
Price-to-Peter-Lynch-Fair-Value 2.52
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.4, Med: 1.8, Max: 13.14
Current: 2.52
0.4
13.14
Price-to-Graham-Number 6.29
Price-to-Graham-Number range over the past 10 years
Min: 1.07, Med: 3.17, Max: 16.03
Current: 6.29
1.07
16.03
Earnings Yield (Joel Greenblatt) % 3.38
Earnings Yield (Greenblatt) range over the past 10 years
Min: 3, Med: 4.7, Max: 21.4
Current: 3.38
3
21.4
Forward Rate of Return (Yacktman) % 18.07
Forward Rate of Return range over the past 10 years
Min: -1.9, Med: 10.8, Max: 25.7
Current: 18.07
-1.9
25.7

More Statistics

Revenue (TTM) (Mil) $ 1,925.3
EPS (TTM) $ 1.18
Beta 1.46
Volatility % 32.86
52-Week Range $ 26.1 - 51.41
Shares Outstanding (Mil) 156.82

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 6
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y